We are live on ! Find out more
NGNE icon

Neurogene
NGNE

39 hedge funds and large institutions have $171M invested in Neurogene in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

18% more funds holding

Funds holding: 33 → 39 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $183M → $171M (-$11.1M)

Holders
39
Holders Change
+6
Holders Change %
+18.18%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
11
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$2.68M
2
NI
Numeric Investors
Massachusetts
+$2.44M
3
RCM
RA Capital Management
Massachusetts
+$1.16M
4
Morgan Stanley
Morgan Stanley
New York
+$829K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$824K

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$7.24M
2
First Manhattan
First Manhattan
New York
-$2.81M
3
GPP
Great Point Partners
Connecticut
-$1.41M
4
HCM
Highbridge Capital Management
New York
-$399K
5
Millennium Management
Millennium Management
New York
-$327K
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
26
Royce & Associates
New York
$232K – – –
Goldman Sachs
27
Goldman Sachs
New York
$225K +$237K +902 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$217K – – –
AIM
29
Ada Investment Management
New York
$205K +$216K +821 New
BIM
30
BlackRock Investment Management
Delaware
$193K – – –
CS
31
Credit Suisse
Switzerland
$188K +$199K +757 New
BCM
32
Bridgeway Capital Management
Texas
$187K – – –
ProShare Advisors
33
ProShare Advisors
Maryland
$173K +$182K +692 New
Northern Trust
34
Northern Trust
Illinois
$168K – – –
PAM
35
Panagora Asset Management
Massachusetts
$50K +$52.6K +200 New
Bank of America
36
Bank of America
North Carolina
$36K +$37.9K +144 New
Citigroup
37
Citigroup
New York
$29K +$30.5K +116 +5,800%
UBS Group
38
UBS Group
Switzerland
$13K -$5K -19 -28%
Barclays
39
Barclays
United Kingdom
$3K +$3.68K +14 New
RG
40
Redmile Group
California
– -$7.24M -25,715 Closed
First Manhattan
41
First Manhattan
New York
– -$2.81M -10,006 Closed
GPP
42
Great Point Partners
Connecticut
– -$1.41M -5,000 Closed
HCM
43
Highbridge Capital Management
New York
– -$399K -1,419 Closed
VKH
44
Virtu KCG Holdings
New York
– -$176K -627 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$53K -186 Closed
SSG
46
Summit Securities Group
New York
– -$1K -5 Closed
1
2

NGNE Hedge Fund Activity: Q4 2015 in Review

39 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2015, worth a combined $171M — down 6.1% from $183M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NGNE positions and 7 closed out — a net gain of 6 holders — while 11 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $2.68M. The largest seller was Redmile Group, exiting entirely with an estimated $7.24M sold.

  • 39 institutional investors held Neurogene (NGNE) as of Q4 2015, up from 33 in Q3 2015.
  • Funds reported $171M of Neurogene stock for Q4 2015, down 6.1% quarter-over-quarter.
  • 13 funds opened new Neurogene positions in Q4 2015 and 7 closed out, a net change of +6 holders.
  • The largest Neurogene buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $2.68M added.
  • The largest Neurogene seller in Q4 2015 was Redmile Group, an estimated $7.24M sold.

Based on aggregated 13F filings for Q4 2015.